GBA1 and amyotrophic lateral sclerosis: Regulates the sphingolipid pathway and glucocerebrosidase activity. In a mouse model of familial ALS, the drug improved motor function and prolonged mice survival Further clinical studies are required to prove its efficacy and safety in ALS patients